Anderson Michele A.
SEC insider (Form 3/4/5 filer). CIK 0002141644. Chief Development Officer at Braveheart Bio, Inc. (BRVE). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in SAN FRANCISCO, CA.
Companies Anderson Michele A. has filed insider reports for
- Braveheart Bio, Inc. (BRVE): Officer, Chief Development Officer
Anderson Michele A.
CIK: 0002141644
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BRVE
Braveheart Bio, Inc.
Officer